OTC Research Issues Review of MIV Therapeutics Inc. DALLAS, Sept. 20, 2005 (PRIMEZONE) -- OTC Research.com has announced a new profile report on MIV Therapeutics, Inc. (OTCBB:MIVT). The report is authored by senior investment analyst, Shailesh Dhuri,...